PRIMECAP MANAGEMENT CO 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-10 12:22 pm Purchase |
2021-12-31 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO | 536,650 14.320% |
23,975![]() (+4.68%) |
Filing |
2021-02-12 12:02 pm Purchase |
2009-02-28 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO | 512,675 14.530% |
9,600![]() (+1.91%) |
Filing |
2020-10-08 7:01 pm Purchase |
2009-02-28 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO | 503,075 14.260% |
28,675![]() (+6.04%) |
Filing |